1. Home
  2. XERS vs MMI Comparison

XERS vs MMI Comparison

Compare XERS & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • MMI
  • Stock Information
  • Founded
  • XERS 2005
  • MMI 1971
  • Country
  • XERS United States
  • MMI United States
  • Employees
  • XERS N/A
  • MMI N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • MMI Real Estate
  • Sector
  • XERS Health Care
  • MMI Finance
  • Exchange
  • XERS Nasdaq
  • MMI Nasdaq
  • Market Cap
  • XERS 1.3B
  • MMI 1.2B
  • IPO Year
  • XERS 2018
  • MMI 2013
  • Fundamental
  • Price
  • XERS $9.25
  • MMI $29.25
  • Analyst Decision
  • XERS Strong Buy
  • MMI Hold
  • Analyst Count
  • XERS 7
  • MMI 1
  • Target Price
  • XERS $8.00
  • MMI N/A
  • AVG Volume (30 Days)
  • XERS 2.2M
  • MMI 125.3K
  • Earning Date
  • XERS 11-07-2025
  • MMI 11-07-2025
  • Dividend Yield
  • XERS N/A
  • MMI 1.71%
  • EPS Growth
  • XERS N/A
  • MMI N/A
  • EPS
  • XERS N/A
  • MMI N/A
  • Revenue
  • XERS $246,025,000.00
  • MMI $725,903,000.00
  • Revenue This Year
  • XERS $43.89
  • MMI $9.50
  • Revenue Next Year
  • XERS $20.40
  • MMI $17.73
  • P/E Ratio
  • XERS N/A
  • MMI N/A
  • Revenue Growth
  • XERS 35.62
  • MMI 17.89
  • 52 Week Low
  • XERS $2.82
  • MMI $27.35
  • 52 Week High
  • XERS $9.41
  • MMI $42.80
  • Technical
  • Relative Strength Index (RSI)
  • XERS 69.43
  • MMI 46.01
  • Support Level
  • XERS $7.78
  • MMI $28.79
  • Resistance Level
  • XERS $8.46
  • MMI $29.62
  • Average True Range (ATR)
  • XERS 0.41
  • MMI 0.67
  • MACD
  • XERS 0.09
  • MMI 0.14
  • Stochastic Oscillator
  • XERS 90.32
  • MMI 80.67

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

Share on Social Networks: